Anthracycline-induced Heart Failure: Treatment and Recovery Prospects-Reference-Cited by-同舟云学术

Anthracycline-induced Heart Failure: Treatment and Recovery Prospects

Published:2024-04-30 Issue:4 Volume:64 Page:79-84
ISSN:2412-5660
Container-title:Kardiologiia
language:
Short-container-title:Kardiologiia

Author:

Vitsenya M. V.¹^ORCID,Potekhina A. V.¹^ORCID,Filatova A. Yu.¹^ORCID,Stukalova O. V.¹^ORCID,Ageev F. T.¹^ORCID

Affiliation:

1. Chazov National Medical Research Center of Cardiology, Moscow

Abstract

The article presents a clinical case of heart failure associated with the anthracycline-containing antitumor therapy in a breast cancer patient with an initially low risk of developing cardiovascular complications.

Publisher

APO Society of Specialists in Heart Failure

Reference9 articles.

1. Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F et al. Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy. Circulation. 2015;131(22):1981–8. DOI: 10.1161/CIRCULATIONAHA.114.013777

2. Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, De Giacomi G et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. Journal of the American College of Cardiology. 2010;55(3):213–20. DOI: 10.1016/j.jacc.2009.03.095

3. Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology. 2017;35(8):893–911. DOI: 10.1200/JCO.2016.70.5400

4. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). European Heart Journal. 2016;37(36):2768–801. DOI: 10.1093/eurheartj/ehw211

5. Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal. 2022;43(41):4229–361. DOI: 10.1093/eurheartj/ehac244